And those changes didnt just show up on the scale
Data from nationwide registers from Sweden, Denmark and Norway showed that patients initiating SGLT-2i were less likely to develop renal adverse events, such as RRT, hospitalization, or death for renal causes, compared to GLP-1RA users [37]
By targeting these pathways, Mounjaro helps reduce hunger, curb cravings, and improve metabolic health
Eloralintide Novos delays and the strategy behind them Lillys surprising phase 2 results (up to 20% weight loss) Combination therapies with tirzepatide or retatrutide 22:30 FDA Pipeline Acceleration Potential removal of traditional phase 3 trials How this speeds up the arrival of next-generation therapies 24:15 Oral GLP-1 Small Molecules (Structure Therapeutics) Alaniglipron data and the stock surge Comparisons to orforglipron and past failures like denuglipron Why Dave remains skeptical 28:40 Sponsor Break: Shed & Shapa Access, coaching, and patient support Using a numberless scale to build a healthier relationship with weight tracking 31:10 Counterfeit Ozempic Warning New fake lot discovered in U.S
Signal Integration by JNK and P38 MAPK Pathways in Cancer Development
Ralph DeFronzo All ingredients are derived from Natural Plants, With No Animal Testing
